Preliminary evaluation of a load-bearing BMP-2 carrier for segmental defect regeneration
- PMID: 16817583
Preliminary evaluation of a load-bearing BMP-2 carrier for segmental defect regeneration
Abstract
Large segmental defects in bones can result from tumor removal, massive trauma, congenital malformation, or non-union fractures. Such defects often are difficult to manage and require multiple-phase surgery to achieve adequate union and function. In this study, we propose a novel design of bone morphogenetic protein 2 (BMP-2) carrier for tissue engineering of segmental defect regeneration. The tube-shaped BMP-2 carrier was fabrication from a poly(propylene fumarate)/tricalcium phosphate (PPF/TCP) composite via casting technique developed in our laboratory. An in vitro evaluation showed that the compressive strength of the carrier decreased about 48% in 12 weeks while maintained a pH in the 6.8-7.4 range. In vivo study was conducted by implanting carriers loaded with 10 microg of BMP-2 in 5 mm rat femur gap model for 15 weeks. X-ray evidence of bridging was first found in the BMP group at 3 weeks. Bridging in all animals (N = 4) in the BMP group was found at 9 weeks. No x-ray evidence of bridging was found in the No BMP group (N = 3). pQCT analysis indicated that the bone mineral density of the callus in the BMP group has reached the level of native femur at 15 weeks after implantation, while the callus in the No BMP group has a bone mineral density at a lower level of 84% to the native femur. Histology analysis shows that a normal fatty bone marrow was restored and mineralized callus formed and bridged the segmental defect.
Similar articles
-
Potentiation of the activity of bone morphogenetic protein-2 in bone regeneration by a PLA-PEG/hydroxyapatite composite.Biomaterials. 2005 Jan;26(1):73-9. doi: 10.1016/j.biomaterials.2004.02.010. Biomaterials. 2005. PMID: 15193882
-
Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant.Biomaterials. 2005 Sep;26(25):5145-52. doi: 10.1016/j.biomaterials.2005.01.054. Biomaterials. 2005. PMID: 15792541
-
Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2.Biotechnol Bioeng. 2008 Mar 1;99(4):996-1006. doi: 10.1002/bit.21648. Biotechnol Bioeng. 2008. PMID: 17879301
-
Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process.Anat Histol Embryol. 2008 Jun;37(3):181-7. doi: 10.1111/j.1439-0264.2007.00824.x. Epub 2007 Dec 7. Anat Histol Embryol. 2008. PMID: 18070240 Review.
-
Bone morphogenetic proteins in clinical applications.ANZ J Surg. 2007 Aug;77(8):626-31. doi: 10.1111/j.1445-2197.2007.04175.x. ANZ J Surg. 2007. PMID: 17635273 Review.
Cited by
-
Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2.Biomaterials. 2007 Jan;28(3):459-67. doi: 10.1016/j.biomaterials.2006.09.004. Epub 2006 Sep 25. Biomaterials. 2007. PMID: 16996588 Free PMC article.
-
Gene-metabolite networks associated with impediment of bone fracture repair in spaceflight.Comput Struct Biotechnol J. 2021 Jun 8;19:3507-3520. doi: 10.1016/j.csbj.2021.05.050. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34194674 Free PMC article.
-
Osteogenic Ability Detection of Human Bone Morphogenetic Protein-2 Gene-activated Nano Bone Putty by Reusable Double-Cavity Bone Harvest Chamber.Orthop Surg. 2017 Feb;9(1):123-128. doi: 10.1111/os.12314. Orthop Surg. 2017. PMID: 28371496 Free PMC article.
-
Effect of Escherichia coli-produced recombinant human bone morphogenetic protein 2 on the regeneration of canine segmental ulnar defects.J Bone Miner Metab. 2012 Jul;30(4):388-99. doi: 10.1007/s00774-011-0329-x. Epub 2011 Nov 2. J Bone Miner Metab. 2012. PMID: 22042292
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous